About this trial
The primary objective of the study is to compare the faecal microbiome pre and post ICI treatment to look got biomarkers of positive treatment response.
Patients who are participating in this study will have stool samples collected at 3 time-points.
The first sample at baseline before starting treatment. The second sample is prior to cycle 2 or 2-4 weeks after the baseline sample. Finally, at approximately 3 months from baseline visit.
These samples will be collected by the patient at home with kits provided by the study. Once the sample is collected the patient will post it directly to the laboratory using the provided paid postage envelopes.
Patient Profile
Patients with metastatic or unresectable solid tumour who are eligible to receive Immune Checkpoint Inhibitor’s(ICI’s) alone or in combination with chemotherapy.
Patients previously treated with ICI’s are not eligible.
Where’s this trial being run?
Bon Secours Cork
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | TAGNEY |
|---|---|
| Number: | 24-19 |
| Full Title: | The Tangney Study: Microbiome Biomarker Prediction of Response to Cancer Therapies |
| Principal Investigator: | Dr Brian Bird |
|---|---|
| Type: | Collaborative |
| Sponsor: | Cork University Hospital |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | |
|---|---|
| Ireland Recruitment Target: |